It is about 6 hours since my first transcranial stimulation session, and I am rapidly forgetting what it was like. I don’t want to forget because it was so interesting, but trying to set it in my memory, it begins to ossify. It helped to compare it to the appointment I had an hour later, which involved a trip to the hairdresser for a touch up of my graying roots, something I do every 5 weeks. Waiting for the color to set takes about 20 minutes, and usually I ask the colorist to put plastic side pieces on my glasses so I can read while I wait. This time I forgot about the glasses, as the colorist disappeared, cell phone on ear. So I just waited, and although I have a pretty busy mind, it was really really boring, and I couldn’t wait for it to be over. Unlike my transcranial stimulation session which was like maybe a kind of trip or journey, and always interesting. Maybe even a “trip” in the other sense of the word, during which my brain was behaving interestingly. Early on, I noticed my eyes seemed to be competing for space on the wall, which bothered me less as the session continued, and sometimes I closed my eyes. I noticed musical phrases, didn’t hear, but imagined them, at first dull ones, later Pavarotti singing "La Donna E Mobile”, then phrases I guess I made up. That didn’t interfere with noticing other phenomena - like having a new insight into my writing of a screenplay, clarifying the premise, which has to be clear for the story to work. And knowing I should find a writing group. I had some realizations about my own past insecurities, but as though they were gone, replaced by a kind of “who cares” feeling, more than that, a feeling of solid confidence. And there were periods of just noticing different states, feelings, hard to describe but all interesting and not at all negative. In fact it was lovely and fun. Like a mind romp. It started somewhere, went other places, started small and got more interesting, changing, at times feeling deeply relaxing. So how do I feel now? Like getting together with a few friends to celebrate.
This study showed that exposing middle aged mice to brief (6 min) stimulation with infrared light over 10 days could markedly improve memory and mood stability. The study completed by Quietmind Foundation has shown this same effect is achieved in similar timeframes with human subjects diagnosed with dementia in the same amount of time using a broad transcranial and intraocular exposure technique. Ongoing trials are being conducted using this device combined with brainwave biofeedback training. Contact Quietmind Fdn. for details. click here for the full paper. original mouse study
Here are some basics on the use of red and near infrared light stimulation. We can't endorse any of the specific products at this time and we think that people need to know that these options exist so they can figure out what works for them in terms of their time, energy and resources to invest in their health and protecting their memory.
I'm noticing a couple of things that are concerning as I've been working to conduct applied clinical trials of the photobiomodulation devices for people with Parkinson's and dementia. We have been met with a surprising lack of responsiveness that I interpret as being subtly passive aggressive. The specific behaviors I associate here relate to a pattern within doctor's staff and physicians themselves avoiding contact with me when I phone to solicit referrals for the trial. After finally getting through to a person after leaving multiple unanswered voicemails, I then got transferred through a maze of people and told to send information and then call the doctor. I send the information and never get to speak with anyone again and am constantly leaving messages on the office voicemail that go unanswered. I finally reach an office person who then connects me to someone else and on it goes while never getting to speak to the doctors. This pattern has repeated on at least 10 different occasions and while I know everyone is busy...this is not really how I expected to be treated when calling to offer free treatment to their patients.
The most recent experience was with a movement disorders specialist whom I reached out to as they were the only such provider in the area where we were attempting to solicit subjects. Several of their patients had already gone through the trial and the responses were encouraging. The subject in the active treatment group improved significantly and the other guy was in the placebo group and didn't notice much of anything and neither did I on the motor and gait testing. The subjects told the doctor they were participating in a new kind of study and the doctor said that she wanted to hear from me and provide more information about the trial. It was on this basis I reached out and when I finally got them on the phone they acted as if they had no idea who I was or why I was calling! I framed the matter as 'this is a very busy person' until I tried to get in touch after being asked to send information on the trial for them to review. I call and get no response, I email twice asking for feedback or a phone appointment to answer questions and solicit subject referrals and get nothing. This is no longer being busy, this is overt avoidance and now I have to ask myself why would they behave this way? What's the dynamic involved here that would have a physician actively avoid allowing their patients to learn about a noninvasive, non-drug treatment option for a disorder for which they have no thoroughly effective treatment? I'm having to conclude that the idea of suggesting a potential treatment that is outside their realm of expertise is inherently threatening even in those cases where the physician also has a background in clinical research as was the case with the movement disorders specialist. The unconscious resistance to change that exists in all of us also extends into this realm wherein doctors will resist allowing their patients to participate in clinical trials that involve ideas and techniques with which they are not expert or in this case have no familiarity. The fact that the risk profile was negligible was not relevant to the reluctance to support their patients participation.
I understand resistance to change is a normal feature of scientific and other social progressive movements and not to be pathologized. Its sad and frustrating to see it operating in this area of clinical research where we are seeking to show the efficacy of a treatment that can help reduce the suffering of millions of people with little to no risk of side effects. Not sure what there is to be done except to look for those doctors who are not easily threatened and who can support their patients’ participation. My frustration and incredulity are best handled by staying focused on the work and remaining optimistic that we will find doctors and support group leaders that will be more positively disposed toward promoting alternative treatment approaches.
Looking for others' thoughts on how best to attract the cooperation and support from clinicians to refer subjects to our trials.
Click here to review the webinar offered to New Mind Lunch and Learn attendees in May, 2017 that outlined the approach Quietmind Foundation is taking to enhance treatment results by integrating photobiomodulation and neurofeedback training technologies.
Dr. Perricone shares his experience of meeting Dr. Gordon Dougal, MD in London who invented the Cognitolite device that we've been studying at Quietmind Fdn. for the past 9 years. The mice in the study weren't actually fitted with helmets, that would have been pretty cute, their cages were fitted with special LED light fixtures and mirrors so the light was reflected into the cages. The results were quite impressive and we now have evidence that these effects are seen in human subjects with age related memory decline and dementia diagnoses. Our clinical trials are now recruiting subjects for at home, free, 60-day use of the Cognitolite photobiomodulation system, for details call 610-940-0488 toll free.
Here is Dr. Nicholas Perricone addressing the concept of light stimualtion's health prototing potential. We have seen the same types of improvement in cognitive and physical functioning resulting from use of these tools in our clinical trials and private practice. Please call to discuss how these technologies could help you.
Bacteria found in Alzheimer patients' brain tissue helps clarify the effectiveness of infrared phototherapy
Bacteria now identified in the brains of people struggling with memory loss has been established now in the research findings of a research group at the University of Bristol in the UK led by Dr. David Emery. This finding reinforces the position Quietmind has taken around the utility of near infrared light stimulation for the treatment of neurodegeneration. Clinical trials are now underway at Quietmind's research center in Elkins Park, PA. Call for details 610-940-0488
Quietmind Foundation's is pleased to announce pubication of the first in man research on the use of transcranial and intraocular 1068nm pulsed near infrared phototherapy effects on cognitive and behavioral symptoms of dementia was published in the April 2017 issue of Neurology and Neuroscience.
Quietmind is collaborating with Baylor, Scott & White Memorial Hospital's Dept. of Neurosurgery to expand on the subject sample and have modified the protocol so that all phototherapy sessions are conducted twice daily by the subject at home over the (30) day study period. Additionally, subjects are being recruited nationally for a similar study for people with age related memory impairment and Parkinson's disease. Call 610-940-0488 for detaisl.
(click to download the paper here nir_helmet_published_paper.pdf .
Biofeedback Pioneer Elmer Green shares insights into migraines, meditation and caring for a spouse with Alzheimer's
Elmer Green Ph.D. was one of the earliest pioneers of biofeedback and helped bring neurophysiology into existence as a field of modern neuroscience. This video clip from 11 KTWU's "Plains People" segment tells some of Elmer's story including his academic training, a 3 month trip to India, and ends with the poignant piece about his views on understanding dementia as he shares his experience of caring for his wife Alyce.
Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general.